CSF1R/c-Kit-IN-1
CSF1R/c-Kit-IN-1 is a CSF-1R and c-Kit inhibitor, with an IC50 of 5.88 nM against human CSF-1R and an IC50 of 1.47 nM against human c-Kit. CSF1R/c-Kit-IN-1 binds to the ATP-binding pocket of CSF-1R, forming a hinge interaction with Cys666 via the oxazole nitrogen atom and adjacent amino group, and binds to residues in the hydrophobic binding pocket. CSF1R/c-Kit-IN-1 binds to the ATP-binding pocket of c-Kit, maintains a hinge interaction through its 2-amino-oxazole core, and binds to a broader hydrophobic surface near the solvent-exposed region via its morpholine substituent. CSF1R/c-Kit-IN-1 inhibits CSF-1-induced phosphorylation of ERK, which is a downstream readout of the CSF-1R signaling pathway. CSF1R/c-Kit-IN-1 can be used in the research of neuroinflammation-related neurodegenerative diseases.
For research use only. We do not sell to patients.
- Formula: C23H22F3N5O4
- Molecular Weight:489.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CSF-1R 5.88 nM (IC50) |
c-Kit 1.47 nM (IC50) |
In Vitro
CSF1R/c-Kit-IN-1 (12l) (40 min) potently inhibits human recombinant CSF-1R kinase with an IC50 of 5.88 nM[1].
CSF1R/c-Kit-IN-1 (20 min pre-incubation; 2 h reaction incubation) potently inhibits c-Kit kinase with an IC50 of 1.47 nM[1].
CSF1R/c-Kit-IN-1 (1.0 μM; 20 min pre-incubation; 2 h reaction incubation) exhibits a cleaner kinome selectivity profile relative to CSF-1R/c-Kit, with weaker off-target activity against FYN, ABL1, and CSK compared to its primary targets[1].
CSF1R/c-Kit-IN-1 (1-10 μM; 30 min pre-incubation; 20 min CSF-1 stimulation) potently and concentration-dependently suppresses CSF-1-induced ERK phosphorylation in SIM-A9 mouse microglial cells, leaving only 18.7% residual pERK signal at 10 μM[1].
CSF1R/c-Kit-IN-1 (10 μM; 6 h) does not reduce SIM-A9 mouse microglial cell viability at a concentration of 10 μM[1].
CSF1R/c-Kit-IN-1 exhibits high human liver microsomal stability, with 86.8% remaining after 30 min of incubation[1].
CSF1R/c-Kit-IN-1 exhibits favorable blood-brain barrier permeability, with an effective permeability coefficient (Pe) of 26.27 × 10-6 cm/s[1].
CSF1R/c-Kit-IN-1 (up to 60 min at room temperature) exhibits excellent human plasma stability, with >100% remaining after 60 min of incubation at room temperature[1].
CSF1R/c-Kit-IN-1 adopts a binding mode that maintains essential hinge interactions in both CSF-1R and c-Kit, with enhanced hydrophobic complementarity in c-Kit contributing to its stronger c-Kit potency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SIM-A9 mouse microglial cells
-
Concentration:1-10 μM
-
Incubation Time:30 min (pre-incubation); 20 min (CSF-1 stimulation)
-
Result:Suppressed CSF-1-induced ERK phosphorylation in a concentration-dependent manner, with 18.7% residual pERK/total ERK signal at 10 μM.
-
Cell Line:SIM-A9 mouse microglial cells
-
Concentration:10 μM
-
Incubation Time:6 h
-
Result:Maintained acceptable cell viability at 10 μM, with viability similar to DMSO control.
Chemical Information
-
Molecular Weight 489.45
-
Formula C23H22F3N5O4
-
SMILES
CC1=C(C=C(C=C1)NC(C2=CC=C(C(C(F)(F)F)=C2)N3CCOCC3)=O)NC(C4=CN=C(O4)N)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)